Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Steven Deeks

Small study hints that revving up immune cells might help fight HIV

Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs

The Independent UK · May 12

‘We are struggling’: doctors faced with vacuum of information on long Covid

‘We are struggling’: doctors faced with vacuum of information on long Covid

Three years into the pandemic, unanswered questions about the condition limit physicians’ ability to treat patients

The Guardian - US · Mar 6, 2023

Treating long COVID means guesswork

Treating long COVID means guesswork

For some, the lingering symptoms from long COVID are worse than the initial bout of the virus

Salon · Nov 29, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Treating long COVID is rife with guesswork

Medical equipment is still strewn around the house of Rick Lucas, 62, nearly two years after he came home from the hospital. He picks up a spirometer, a device that measures lung capacity, and takes a deep breath — though not as deep as he’d like.

Tribune News Service · Nov 27, 2022

Long-COVID clinics are wrestling with how to treat their patients

The clinics have popped up all over the country, but doctors still don't know the best way to treat these patients, whose symptoms can vary dramatically.

WEKU · Nov 18, 2022

More people are catching coronavirus a second time, heightening long COVID risk, experts say

LOS ANGELES — Emerging evidence suggests that catching the coronavirus a second time can heighten long-term health risks, a worrisome development as the circulation of increasingly contagious omicron subvariants leads to greater numbers of Californians being reinfected.

Los Angeles Times · Aug 1, 2022

Two long COVID Patients Recover After Pfizer's Therapy; Side Effects, Safety Needs To Be Assessed: Reuters

Reuters reported that two patients found relief from long COVID after taking Pfizer Inc's (NYSE:PFE) antiviral Paxlovid, including a researcher who tested it on herself. Long COVID is estimated to affect up to 30% of people infected with the coronavirus. It can last for months. More than 200 symptoms have been associated with the…

Benzinga · Apr 18, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

New clues emerge on long COVID

New clues emerge on long COVID

If confirmed, clinicians "can actually design interventions to make people better," said UC San Francisco's Steven Deeks.

Axios · Jan 27, 2022

1

Coverage From

People

Ezekiel Emanuel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

University of California

National Institutes of Health

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

424,194 stories

150,496 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play